MENU
+Compare
XLV
ETF ticker: NYSE ARCA
AS OF
Oct 17, 04:59 PM (EDT)
Price
$143.24
Change
+$0.92 (+0.65%)
Net Assets
35.89B

XLV stock forecast, quote, news & analysis

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index... Show more

Category: #Health
XLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
A.I.Advisor
a Summary for XLV with price predictions
Oct 16, 2025

Momentum Indicator for XLV turns negative, indicating new downward trend

XLV saw its Momentum Indicator move below the 0 level on October 15, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned negative. In of the 93 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for XLV moved out of overbought territory on October 10, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where XLV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for XLV turned negative on October 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XLV broke above its upper Bollinger Band on October 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

XLV moved above its 50-day moving average on September 26, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in of 348 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 295 cases where XLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Abbott Laboratories (NYSE:ABT), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Gilead Sciences (NASDAQ:GILD), Boston Scientific Corp (NYSE:BSX).

Industry description

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Market Cap

The average market capitalization across the The Health Care Select Sector SPDR® ETF ETF is 84.45B. The market cap for tickers in the group ranges from 7.52B to 734.54B. LLY holds the highest valuation in this group at 734.54B. The lowest valued company is HSIC at 7.52B.

High and low price notable news

The average weekly price growth across all stocks in the The Health Care Select Sector SPDR® ETF ETF was 7%. For the same ETF, the average monthly price growth was 20%, and the average quarterly price growth was 65%. CVS experienced the highest price growth at 6%, while HUM experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the The Health Care Select Sector SPDR® ETF ETF was 11%. For the same stocks of the ETF, the average monthly volume growth was -13% and the average quarterly volume growth was -27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 57
Price Growth Rating: 51
SMR Rating: 100
Profit Risk Rating: 68
Seasonality Score: 23 (-100 ... +100)
View a ticker or compare two or three
XLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
One Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com